Search of: "Lopinavir/Ritonavir" [TREATMENT] AND HIV [CONDITION] - List Results

Home


	List Results


	Refine Search


	Results by Topic


	Results on Map


	Search Details

Found 160 studies with search of:

"Lopinavir/Ritonavir" [TREATMENT] AND HIV [CONDITION]

Hide studies that are not seeking new volunteers.

Display Options

1	Recruiting	Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-Partum Phase. ANRS 135 Primeva
		Condition:	HIV Infections
		Interventions:	Drug: Kaletra (lopinavir/ritonavir); Drug: Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine)

2	Terminated	Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients
		Conditions:	HIV Infections; Kaletra
		Interventions:	Drug: lopinavir/ritonavir; Drug: lopinavir /ritonavir

3	Recruiting	Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
		Condition:	HIV Infections
		Interventions:	Drug: Lopinavir/ritonavir; Drug: Lopinavir/ritonavir; Drug: Lopinavir/ritonavir

4	Recruiting	Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)
		Condition:	HIV Infections
		Interventions:	Drug: Kaletra (lopinavir/ritonavir); Drug: buprenorphine; Other: Clinical evaluations/Blood draws

5	Completed	Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients
		Condition:	HIV Infection
		Interventions:	Drug: lopinavir/ritonavir; Drug: lamivudine/zidovudine

6	Completed	Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients
		Condition:	HIV Infection
		Interventions:	Drug: Tenofovir DF; Drug: lopinavir/ritonavir with 2 Nucleoside RTIs

7	Terminated	Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV co-Infected Subjects vs Baseline Liver Biopsy Metavir Score
		Condition:	HIV Infection
		Intervention:	Drug: Lopinavir/Ritonavir

8	Enrolling by invitation	Comparison of Liquid Kaletra and Low Dose Kaletra Tablets
		Condition:	HIV Infections
		Intervention:	Drug: Low dose Kaletra tablets

9	Recruiting	Metabolic Effects of Switching Kaletra to Boosted Reyataz
		Condition:	HIV Infections
		Interventions:	Drug: atazanavir/ritonavir; Drug: lopinavir/ritonavir

10	Recruiting	Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy
		Conditions:	HIV Infections; Pregnancy
		Interventions:	Drug: Lopinavir / ritonavir; Drug: Lopinavir/ritonavir

11	Terminated	GW873140 In Combination With Kaletra In HIV Infected Subjects
		Condition:	HIV Infection
		Interventions:	Drug: GW873140; Drug: Kaletra (lopinavir/ritonavir)

12	Recruiting	Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-Infected Patients
		Condition:	HIV Infections
		Intervention:	Drug: lopinavir/ritonavir and raltegravir

13	Recruiting	Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir
		Condition:	HIV Infections
		Interventions:	Drug: Lumefantrine - lopinavir/ritonavir drug interaction; Drug: Lumefantrine only arm

14	Recruiting	Kaletra and Viread in Antiretroviral Naïve Patients
		Condition:	HIV Infections
		Intervention:	Drug: Lopinavir/ritonavir and tenofovir

15	Completed	Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
		Condition:	HIV Infections
		Interventions:	Drug: lopinavir/ritonavir (tablet or capsule) with NRTIs; Drug: lopinavir/ritonavir (tablet or capsule) with NRTIs; Drug: lopinavir/ritonavir (tablet or capsule) with NRTIs; Drug: lopinavir/ritonavir cap (tablet or capsule) with NRTIs

16	Recruiting	Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects
		Condition:	HIV Infections
		Interventions:	Drug: Raltegravir and Lopinavir/ritonavir; Drug: Raltegravir, emtricitabine, tenofovir

17	Active, not recruiting	A Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Dosing in Antiretroviral-Experienced, HIV-1 Infected Subjects
		Condition:	HIV Infection
		Interventions:	Drug: lopinavir/ritonavir; Drug: lopinavir/ritonavir

18	Recruiting	Lopinavir Capsules to Kaletra or Invirase Tablets
		Condition:	HIV Infections
		Interventions:	Drug: Saquinavir (Invirase®); Drug: Lopinavir/ritonavir (Kaletra®)

19	Completed	Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil
		Conditions:	HIV Infections; Cholesterol
		Interventions:	Drug: Lopinavir/Ritonavir; Drug: Gemfibrozil

20	Recruiting	Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
		Condition:	HIV Infection
		Interventions:	Drug: lopinavir/ritonavir (LPV/r); Drug: emtricitabine/tenofovir disoproxil fumarate (FTC/TDF); Drug: raltegravir (RAL)

21	Suspended	Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients
		Condition:	HIV Infection
		Interventions:	Drug: atazanavir; Drug: lopinavir/ritonavir

22	Recruiting	Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients
		Condition:	HIV Infections
		Interventions:	Drug: Kaletra + Isentress; Drug: Atripla

23	Recruiting	Kaletra Sex/Gender Pharmacokinetics (PK) Study: A Switch From Twice Daily to Once Daily Lopinavir/Ritonavir
		Condition:	HIV Infections
		Intervention:	Drug: Kaletra

24	Completed	A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects
		Condition:	HIV Infections
		Interventions:	Drug: Kaletra® (lopinavir/ritonavir); Drug: Combivir® (lamivudine, zidovudine); Drug: Sustiva® (efavirenz)

25	Recruiting	Kaletra-Isentress Treatment Evaluation
		Condition:	HIV Infections
		Interventions:	Drug: Kaletra + Isentress; Drug: Standard HAART Regimen

26	Active, not recruiting	Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants
		Condition:	HIV Infections
		Intervention:	Drug: Lopinavir/Ritonavir

27	Active, not recruiting	Raltegravir Insulin Sensitivity Study
		Condition:	HIV Infections
		Interventions:	Drug: Raltegravir then lopinavir/ritonavir; Drug: Lopinavir/ritonavir then raltegravir

28	Active, not recruiting	Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
		Condition:	HIV Infections
		Interventions:	Drug: Lopinavir/Ritonavir; Drug: Ritonavir; Drug: GW433908

29	Not yet recruiting	Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women
		Condition:	HIV Infections
		Intervention:	Drug: generic lopinavir/ritonavir

30	Active, not recruiting	MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)
		Conditions:	HIV Infections; HIV-Associated Lipodystrophy Syndrome
		Interventions:	Drug: Lopinavir/ritonavir + zidovudine + lamivudine; Drug: Lopinavir/ritonavir + nevirapine

31	Recruiting	Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients
		Condition:	HIV Infections
		Intervention:	Drug: Kaletra

32	Completed	BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)
		Condition:	HIV Infections
		Intervention:	Drug: Increased dose of Kaletra

33	Completed	ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects
		Condition:	HIV Infections
		Interventions:	Drug: Lopinavir/Ritonavir; Drug: Lamivudine; Drug: Stavudine

34	Completed	Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance
		Condition:	HIV Infections
		Interventions:	Drug: Lopinavir/ritonavir; Drug: Ritonavir; Drug: Saquinavir; Drug: Tenofovir disoproxil fumarate; Drug: Amprenavir

35	Recruiting	Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-Based HAART in Advanced HIV Disease
		Condition:	Acquired Immune Deficiency Syndrome
		Interventions:	Drug: Lopinavir-ritonavir; Drug: Efavirenz

36	Recruiting	Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations
		Conditions:	HIV Infections; Malaria
		Interventions:	Drug: lopinavir/ritonavir; Drug: efavirenz; Drug: artemether/lumefantrine

37	Recruiting	Prospective, Open Label and Randomized Clinical Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra vs Nevirapine in co-Infected HIV/HCV Patients
		Condition:	HIV Infections
		Interventions:	Drug: Lopinavir/ritonavir; Drug: Nevirapine

38	Withdrawn	A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects
		Conditions:	HIV Infection; Hepatitis C
		Interventions:	Drug: Kaletra (lopinavir/ritonavir); Drug: Sustiva (efavirenz); Drug: Truvada (emtricitabine/tenofovir disoproxil fumarate)

39	Active, not recruiting	Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
		Condition:	HIV Infections
		Intervention:	Drug: Lopinavir/ritonavir

40	Active, not recruiting	Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients
		Condition:	HIV Infections
		Intervention:	Drug: Lopinavir/ritonavir (drug)

41	Recruiting	Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV
		Condition:	HIV Infections
		Interventions:	Drug: Trizivir; Drug: Lamivudine/Zidovudine; Drug: Lopinavir/Ritonavir; Drug: Nevirapine

42	Recruiting	Kaletra Monotherapy in HIV/HCV Co-Infected Subjects
		Condition:	HIV Infections
		Intervention:	Drug: Kaletra Tablets

43	Completed	Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
		Condition:	HIV Infections
		Interventions:	Drug: Lopinavir/ritonavir; Drug: Efavirenz; Drug: Stavudine; Drug: Zidovudine; Drug: Lamivudine; Drug: Tenofovir disoproxil fumarate

44	Active, not recruiting	Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection
		Condition:	HIV Infections
		Interventions:	Drug: Abacavir sulfate, Lamivudine, and Zidovudine; Drug: Lopinavir/Ritonavir

45	Completed	Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People
		Condition:	HIV Infections
		Interventions:	Drug: Fosamprenavir; Drug: Lopinavir/Ritonavir; Drug: Ritonavir; Drug: Tenofovir disoproxil fumarate

46	Terminated	Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy
		Condition:	HIV Infection
		Intervention:	Drug: Lopinavir/Ritonavir

47	Completed	"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects
		Condition:	HIV Infection
		Intervention:	Drug: Stopping nucleosides and continuing lopinavir/ritonavir monotherapy

48	Completed	Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women
		Conditions:	HIV Infections; Pregnancy
		Interventions:	Drug: Lopinavir/ritonavir; Drug: Ortho Novum 1/35; Drug: Ortho Evra

49	Recruiting	Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy
		Condition:	HIV Infections
		Interventions:	Drug: Emtricitabine/Tenofovir disoproxil fumarate; Drug: Lopinavir/Ritonavir

50	Completed	Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects
		Condition:	HIV Infections
		Interventions:	Drug: Lopinavir/ritonavir; Drug: Saquinavir mesylate; Drug: Lamivudine/zidovudine

Studies Shown (1-50)

Next (51-100)

RSS Feed for studies found by your search that were received in the last 14 days

Download Options